Convalescent Plasma News and Research

RSS
mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

mRNA vaccines and monoclonal antibodies protect against new NYC-B.1.526 variant

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

Detecting SARS-CoV-2 specific IgG antibodies with the Kantaro Covid-SeroKlir Kit

Study suggests SARS-CoV-2 antibodies in breast milk are robust, neutralizing and durable

Study suggests SARS-CoV-2 antibodies in breast milk are robust, neutralizing and durable

A green tea compound shows anti-SARS-CoV-2 properties in vitro

A green tea compound shows anti-SARS-CoV-2 properties in vitro

Prediction of antibody responses in recovered COVID-19 patients remains unclear

Prediction of antibody responses in recovered COVID-19 patients remains unclear

The hype has faded, but don’t count out convalescent plasma in Covid battle

The hype has faded, but don’t count out convalescent plasma in Covid battle

Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation

Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion

How resistant is the SARS-CoV-2 Brazilian variant to antibodies?

How resistant is the SARS-CoV-2 Brazilian variant to antibodies?

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

What is a protective neutralizing antibody titer against SARS-CoV-2 infection?

Why does convalescent plasma therapy for severe COVID-19 show mixed success?

Why does convalescent plasma therapy for severe COVID-19 show mixed success?

Neutralizing nanobodies effective against SARS-CoV-2 variants

Neutralizing nanobodies effective against SARS-CoV-2 variants

Study maps crucial component of long-term immune response to SARS-CoV-2

Study maps crucial component of long-term immune response to SARS-CoV-2

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

Impact of type I interferon (IFN) autoantibodies in critical COVID-19

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Spike protein mutations in SARS-CoV-2 variants help resist antibody neutralization

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Researcher find an emergent SARS-CoV-2 variant in California

Researcher find an emergent SARS-CoV-2 variant in California

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

Study: Monoclonal antibody 'cocktail' effective against all known COVID-19 variants

Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

Brazilian SARS-CoV-2 P.1 variant shows resistance to antibody neutralization

Delayed detection of oral fluid anti-SARS-CoV-2 antibodies increases the time to viral clearance

Delayed detection of oral fluid anti-SARS-CoV-2 antibodies increases the time to viral clearance